At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy ...
A drug from the same family licensed for use in patients with Duchenne muscular dystrophy and blood cancer could transform ...
SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy (“Duchenne” or ...
The U.S. Food and Drug Administration (FDA) accepted on Tuesday Sarepta Therapeutics Inc.’s SRPT supplemental New Drug ...
Shares of Sarepta Therapeutics rose after the Food and Drug Administration accepted the company's supplemental new drug applications for two treatments for Duchenne muscular dystrophy. The stock ...
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that the Cellular, Tissue, and Gene ...
Add Yahoo as a preferred source to see more of our stories on Google. When Conner Curran was first diagnosed with Duchenne muscular dystrophy at age 4, his parents were told there was nothing they ...
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...
Capricor Therapeutics (CAPR) stock drops as the company faces an FDA advisory committee meeting in the review for its ...
Dear Mayo Clinic: What is Duchenne muscular dystrophy, and what causes it? Is treatment available? Can Duchenne muscular dystrophy be cured? Muscular dystrophy is an umbrella term applied to a group ...
Jamesy Raffone of Manalapan is defying the experts, learning to drive despite Duchenne muscular dystrophy. The man least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results